Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-42.22	-86.77	-61.01
Graham Fair Price	36.71	12.82	9.38
PEG	-87.35	-0.09	0.73
Price/Book	-55.56	19.11	43.00
Price/Cash Flow	13.87	-57.86	-67.18
Prices/Earnings	31.55	16.65	-12.66
Price/Sales	-20.86	61.77	78.05
Price/FCF	13.87	-57.86	-67.18
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-5.98	0.92	0.98
Operating Margin	43.86	-0.82	-1.46
ROA	-18.80	0.09	-0.11
ROE	-0.85	0.29	-66.22
ROIC	-0.13	-0.09	25.85
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.23	5.15	-95.58
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.19	0.25	35.13
EPS QOQ	0.17	1.80	940.20
FCF QOQ	0.25	-0.23	-7.17
Revenue QOQ	0.27	0.34	23.39
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	1066.48	348.03	-67.37
Days Sales Outstanding (DSO)	54.00	56.23	4.11
Inventory Turnover	0.08	0.26	206.43
Debt/Capitalization	0.84	0.63	-25.62
Quick Ratio	3.51	3.43	-2.30
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	2.14	5.05	135.21
Cash	11.67	10.52	-9.85
Capex	-0.08	-0.02	76.64
Free Cash Flow	-1.37	-1.67	-21.37
Revenue	1.18	1.56	32.08
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	3.76	3.76	-0.06
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-6.79	-6.55	3.51
Naive Interpretation	Member

06 - Financial Health · Bad

Rating